Steven G. Brodie, President, Pharma Services at NEOGENOMICS INC (NEO), sold 50,000 shares at $8.00 ($397K) on 2017-03-13, disclosed to the SEC on 2017-03-22.
Scheduled sale ($397k) by President, Pharma Services.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 16,550 | $132K | 33.4% |
| 2 | $7.90 | 33,450 | $264K | 66.6% |
| Total | $7.93 avg | 50,000 | $397K | 100% |